Validation of R&D-Intensive Projects for Public and Private Funds
Comprehensive Scientific & Technological Expertise
We provide independent, top-tier expertise for technological proposals. We help decision-makers separate fundamentally strong developments from populism, technological dead ends, and market hype.
Scientific Due Diligence
Comprehensive evaluation of deep-tech and biotech startups. We validate scientific claims, assess technical feasibility, identify execution bottlenecks, and analyze economic viability before you deploy capital.
Deliverables: Independent evaluation report, technology risk scoring card, and expert summary.
Grant Proposal Evaluation
Rigorous peer review of scientific research proposals. Our global network of PhD-level reviewers evaluates methodologies, novelty, and societal or commercial impact to help funding bodies select top-tier projects.
Deliverables: Peer-review consensus reports, ranked proposal scoring, and compliance check.
Technology Scouting & Sourcing
Proactive identification of emerging technologies and academic discoveries that match your corporate innovation roadmap. We bridge the gap between breakthrough lab research and industrial application.
Deliverables: Global technology landscape map, target shortlists, and partnership compatibility analysis.
IP & Regulatory Affairs Advisory
Pre-regulatory assessment of preclinical and clinical data. We evaluate intellectual property robustness and verify alignment with international standards set by global regulators like FDA and EMA.
Deliverables: Regulatory gap analysis, IP freedom-to-operate scientific brief, and roadmap to compliance.
Bioinformatics & Computational Modeling
Advanced statistical modeling and AI-driven analysis of complex data sets. Designed for genomic research, clinical trial analytics, and high-performance mathematical computing in natural sciences.
Deliverables: Custom analytical pipelines, data validation reports, and predictive model architectures.
Challenges of Modern Science
The Cost of Mistake
Allocating multi-million dollar grants to inherently unviable concepts is not just a budget loss. It is lost time in the global technological race.
Data Irreproducibility and Academic Misconduct
Driven by the pressure to secure funding and high-impact publications, some research teams resort to selective reporting or outright data manipulation. Detecting well-masked flaws in raw experimental data is impossible through standard auditing. This creates catastrophic risks for investors backing what is essentially a fabricated breakthrough.
The Risk of Honest Misconception
Conscientious scientific teams often achieve outstanding fundamental results, yet they can be honestly mistaken about their commercial or engineering feasibility. A project may be flawless in laboratory settings but unfeasible on an industrial or clinical scale.
Market Hype and Scientific Populism
Growing interest in Advanced Materials, Green Chemistry, and Life Sciences has led to an influx of pseudo-scientific pitches. Behind beautiful charts often lie concepts that lack basic validation. Without deep, specialized expertise, general managers and investors cannot distinguish real science from transient trends.